Small Cap Feast

Small Cap Feast – 27th February 2017

Dish of the Day:

LXI REIT has joined the Official List raising £138.15m at 100p. Yield play targeting minimum dividend of 5p for year beginning Apr 2018

 

Off the Menu:

No AIM Leavers Today

What’s Cooking in the IPO Kitchen?

Anglo African Oil & Gas— Admission expected early March. Acquiring stake in producing near offshore field in the Republic of the Congo.

Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime.  Admission now due 7 March

 

Breakfast Buffet

InnovaDerma* (IDP.L) 133p £15.75m

The UK developer of ‘at-home’ and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation,  has acquired the Intellectual Property and Assets of the ‘Stevie K’ (award winning, mid-premium priced, bold range of cosmetics) and ‘Charles + Lee’ (affordable alternative premium range of men’s skincare) brands. The purchase price for the Acquisitions is AUS$50,000, with the option to convert into equity. “Stevie K and Charles + Lee are an excellent strategic fit for InnovaDerma and we are pleased to have acquired such highly differentiated brands which the Board believes will bring considerable international growth opportunities. We welcome Kate Fissenden to the Company and look forward to working with her to drive profitable growth in the future.” Kate is the founder of both brands and will be responsible for the growth and development of both

 

Botswana Diamonds (BOD.L) 1.82p £6.18m

£525k placing at 1.5p with new and existing investors. The net proceeds of the Placing will be used to fund ongoing kimberlite drilling at the Frischgewaagt property in South Africa, drilling in Botswana, exploration work in South Africa and in the first stage of the 2017 Alrosa/Botswana Diamonds exploration programme in the Orapa and Gope areas of Botswana.

WH Ireland (WHI.L) 124.5p £34.22m

FYNov16 results from the financial services group that provides private wealth management and corporate broking services. Group turnover of £25.4m (2015: £30.9m). Operating loss of £1.3m before exceptional items (2015: profit of £1.1m). Exceptional items of £1.8m (2015: £1.2m). Cash reserves of £6.7m (Including post year end proceeds of property sale, cash reserves approximately £11m). Wealth Management: Assets under management increased by 14% to £2,872m. Corporate broking: Corporate clients 85 (2015: 98 clients). H2 saw a rebound in capital raisings environment. “Opportunities for acquisitive growth need to be identified and executed but we will focus significantly more activity in this area than in previous years. Our new shareholder also offers the potential for supplemental business growth for the Company both from, and to, the Middle East.”

 

InfraStrata (INFA.L) 0.68p £1.27m

The independent gas storage company, announced its intention to conduct a placing of new ordinary shares to raise a total of up to £750,000 before expenses. It is intended that the new ordinary shares will be issued at 0.5 pence per new ordinary share. The Placing will be conducted by way of an accelerated book build. The proceeds will be used to repay the Baron Oil Loan (£200k), for working capital and to complete the first phase of the Front-End Engineering Design  (FEED) project for the above-ground facilities and the sub-surface elements of its Islandmagee gas storage project.

 

ECR Minerals (ECR.L) 1.15p £1.49m

The Company has conditionally raised gross proceeds of £553,564  pursuant to a subscription by the Shenyang Xinliaoan Machinery Co Ltd for a stake of 29.9% at  2p. Proceeds to be used for drilling programmes in Australia and Argentina and working capital including review of potential new projects and business areas. Shares locked up for 12 months.

 

Union Jack Oil (UJO.L) 0.16p £5.28m

The Company has raised approximately £1.4 million gross at 0.135p. The Company, which is currently fully funded for its existing commitments, which include the drilling of the Biscathorpe-2 and Holmwood-1 conventional exploration wells, intends to utilise the proceeds of the Placing to increase its interests in existing licences within the Company’s portfolio. Management are working towards concluding these acquisitions in the near term.

 

Arsenal Holdings (NEX:AFC) £1725 £1.1bn

Announced HY Nov16 results on Friday. Turnover from football increased to GBP191.1 million (2015 – GBP158.0 million) with growth in broadcasting distributions at the start of a new three year     revenue cycle for the Premier League and an increased share of UEFA   Champions League market pool. The Club invested strongly in its playing squad. Higher player wages were the single largest contributory factor in the Club’s increased operating    costs whilst, in terms of transfers, the Club invested at record levels, adding GBP110.5 million to the cost of player registrations. PBT of £12.6m from £6.2m.

 

GlobalData (DATA.L) 582.5p £595.6m

FY Dec16 results from the data and insights solutions provider.    Group revenue increased by 65% to £100.0m. Deferred revenue increased by 57% to £46.1m. Adjusted EBITDA increased by 71% to £20.6m. Final divi up to 4p from 2.5p.  The results for the year include a full twelve-month contribution from our recent Consumer and GlobalData acquisitions, whereas the prior year comparatives include no contribution from the Healthcare acquisition (completed January 2016) and only a part year contribution from the Consumer acquisition (completed September 2015). Net debt flat at £25.4m.

 

Thor Mining (THOR.L) 0.75p £2.75m

HY Dec16 results. Pilot Mountain (USA): Regulatory approvals received for drilling programs at the Garnet tungsten target and the Desert Scheelite copper/tungsten target. Molyhil (Australia): Successful aircore drilling program testing anomalies adjacent to the Molyhil Tungsten Project provided impetus to apply for an additional licence area contiguous with one tested prospect. Dundas (Australia): Advanced planning for new drilling program at Dundas gold project. Detailed appraisal of a number of potential new projects, including a specific focus on mainstream commodities. £394k op loss and £588k FX gain. A$1.5mreceived post ear end from asset sale.

 

Starcom (STAR.L) 2p £3.06m

FYDec16 trading update from the specialist in the development of wireless solutions for the remote tracking, monitoring and protection of a variety of assets and people. The Board expects turnover of not less than US$5.2m (FY 2015: US$5.1m). Growth in revenues from the new Watchlock Pro has been held back due to delays in deliveries by Mul-T-Lok. An order of US$200,000, originally planned for delivery in 2016, will now be shipped and recognised in the 2017 financial year. The Company has now addressed this problem to ensure that it can meet the demand in a timely manner. Expects $1.5m pre-tax loss. Expects improved performance in 2017.

 

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.